Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Triolo

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Rheumatology (Oxford, England)|October 6, 2018
Dose adjustments and discontinuation in TNF inhibitors treated patients: when and how. A systematic review of literaturePiero Ruscitti, Luigi Sinigaglia, Massimiliano Cazzato, et al.
Arthritis and Rheumatism|March 13, 2003
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodiesGiovanni Triolo, Angelo Ferrante, Francesco Ciccia, et al.
Arthritis Research & Therapy|June 8, 2010
Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicityAntonina Accardo-Palumbo, Anna Rita Giardina, Francesco Ciccia, et al.
European Journal of Immunology|August 18, 2017
IL-17 polarization of MAIT cells is derived from the activation of two different pathwaysGiuliana Guggino, Diana Di Liberto, Marianna Lo Pizzo, et al.
Arthritis Research & Therapy|August 23, 2003
Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active diseaseGiovanni Triolo, Antonina Accardo-Palumbo, Francesco Dieli, et al.
The Journal of Rheumatology|August 9, 2008
Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infectionClodoveo Ferri, Gianfranco Ferraccioli, Daniela Ferrari, et al.
The Clinical Respiratory Journal|April 3, 2015
Physical capacity in performing daily activities is reduced in scleroderma patients with early lung involvementSalvatore Battaglia, Maria Bellia, Laura Serafino-Agrusa, et al.
Rheumatology International|April 24, 2009
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritisA Ferrante, A R Giardina, F Ciccia, et al.
Cytotherapy|February 15, 2015
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapiesPaola Cipriani, Piero Ruscitti, Paola Di Benedetto, et al.
Journal of the Neurological Sciences|May 14, 2004
Cognitive impairment in Behçet's disease patients without overt neurological involvementRoberto Monastero, Cecilia Camarda, Carmela Pipia, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Rheumatology (Oxford, England)|October 6, 2018
Dose adjustments and discontinuation in TNF inhibitors treated patients: when and how. A systematic review of literaturePiero Ruscitti, Luigi Sinigaglia, Massimiliano Cazzato, et al.
Arthritis and Rheumatism|March 13, 2003
Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodiesGiovanni Triolo, Angelo Ferrante, Francesco Ciccia, et al.
Arthritis Research & Therapy|June 8, 2010
Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicityAntonina Accardo-Palumbo, Anna Rita Giardina, Francesco Ciccia, et al.
European Journal of Immunology|August 18, 2017
IL-17 polarization of MAIT cells is derived from the activation of two different pathwaysGiuliana Guggino, Diana Di Liberto, Marianna Lo Pizzo, et al.
Arthritis Research & Therapy|August 23, 2003
Vgamma9/Vdelta2 T lymphocytes in Italian patients with Behçet's disease: evidence for expansion, and tumour necrosis factor receptor II and interleukin-12 receptor beta1 expression in active diseaseGiovanni Triolo, Antonina Accardo-Palumbo, Francesco Dieli, et al.
The Journal of Rheumatology|August 9, 2008
Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infectionClodoveo Ferri, Gianfranco Ferraccioli, Daniela Ferrari, et al.
The Clinical Respiratory Journal|April 3, 2015
Physical capacity in performing daily activities is reduced in scleroderma patients with early lung involvementSalvatore Battaglia, Maria Bellia, Laura Serafino-Agrusa, et al.
Rheumatology International|April 24, 2009
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritisA Ferrante, A R Giardina, F Ciccia, et al.
Cytotherapy|February 15, 2015
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapiesPaola Cipriani, Piero Ruscitti, Paola Di Benedetto, et al.
Journal of the Neurological Sciences|May 14, 2004
Cognitive impairment in Behçet's disease patients without overt neurological involvementRoberto Monastero, Cecilia Camarda, Carmela Pipia, et al.
Pageof 10